No Need to Sugarcoat the Message: Is Cardiovascular Risk Reduction From SGLT2 Inhibition Related to Natriuresis?

Am J Kidney Dis. 2016 Sep;68(3):349-52. doi: 10.1053/j.ajkd.2016.03.410. Epub 2016 Mar 30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Hypoglycemic Agents
  • Natriuresis / drug effects*
  • Risk Factors
  • Sodium-Glucose Transporter 2

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2